Unresolved Policy Issues Impact Patient Access to Biosimilars
Improving Patient Access to Hepatitis C Cures
Informed Prescribing: Physicians Need Complete and Specific Prescribing Information for Biosimilar Medications
Access to Integrated Care for Chronic Pain
Abuse-Deterrent Opioid Formulations: Promising Technology, Unique Challenges
Protecting Cancer Care: Improving Transparency and Patient Access
What is Indication Extrapolation and Should it be Allowed with Biological Medications?
Ensure Patient Safety When Naming Biological Medications
The True Costs of Health Plan Specialty Tiers
Biologics: Can Patients Get What The Doctor Orders?
